Skip to main content

Certara, Inc.

CERT
Exchange
Nasdaq
Industry
Services-Prepackaged Software
SEC CIK
0001827090

No open-market purchases or sales by Certara, Inc. insiders were filed in the last 90 days; 241 institutions reported holding it in 13F filings for Q2 2026, worth $880.2M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Certara, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Certara, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Certara, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Mohammed FaizInterim CFO–Sep 2, 20261
Anhalt RonaChief Human Resources Officer16,789Jun 2, 20263
Corcoran DanielSVP and General Counsel32,046Jun 2, 20263
Cashman James E IIIDirector, Other: Chairman484,197May 15, 20261
Broshy EranDirector, Other: Chairman50,708May 15, 20261
Walsh Matthew MDirector213,316May 15, 20261
Collins CynthiaDirector51,846May 15, 20261
Crane Rosemary ADirector45,672May 15, 20261
Killefer NancyDirector51,846May 15, 20261
Reynders John V WChief Financial Officer26,466May 15, 20261
Bedi ArjunDirector5,547May 15, 20262
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFF110,045May 13, 20262
Gallagher John EChief Financial Officer95,371May 13, 20262
Aspbury RobertPRESIDENT, PREDICTIVE TECH332,442May 13, 20262
Resnick Jon MatthewChief Executive Officer35,389May 13, 20261
McKemey AdrianPresident, Drug Dev. Solutions8,207Apr 3, 20261
Feehery William FCHIEF EXECUTIVE OFFICER2,360,769Nov 12, 20251
Smith Patrick FPRESIDENT, DRUG DEV SOLUTIONS50,091Oct 8, 20240
Traynor Richard M.SVP AND GENERAL COUNSEL173,524Apr 3, 20240
Sherman Nicolette DCHIEF HUMAN RESOURCES OFFICER24,358Apr 3, 20240
Schemick Michael AndrewCHIEF FINANCIAL OFFICER522,895Apr 3, 20230
Virkler DraytonPRESIDENT, REG & ACCES12,415Apr 3, 20230
EQT Avatar Parent L.P.10% Owner0IndirectDec 12, 20220
EQT Avatar Parent GP LLC10% Owner0IndirectDec 12, 20220
EQT Fund Management S.a r.l.10% Owner0IndirectDec 12, 20220
Slaine Mason PDirector660,322Nov 16, 20220
McLean Stephen M.Director42,000Aug 23, 20220
Choe Jieun W.CHIEF STRATEGY & MARKETING248,577Apr 5, 20220
Edge JustinPRES., REGULATORY & ACCESS394,764Apr 5, 20220
Rayner Craig R.PRESIDENT, INTEGRATED DRUG DEV316,010Sep 7, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 12, 2025 (view filing)Nov 111 dayFeehery William FCHIEF EXECUTIVE OFFICERPPurchase+24.1K$8.30+$200.0K+1.0%2.36M after
Sep 11, 2025 (view filing)Sep 92 daysPedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFSSale−51.2K$10.92−$559.4K−40.9%74.0K after10b5-1
Oct 8, 2024 (view filing)Oct 71 daySmith Patrick FPRESIDENT, DRUG DEV SOLUTIONSSSale−5.41K$11.03−$59.7K−9.7%50.1K after10b5-1
Sep 10, 2024 (view filing)Sep 91 dayPedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFSSale−51.2K$11.29−$578.3K−33.9%99.7K after10b5-1
Apr 4, 2024 (view filing)Apr 22 daysSmith Patrick FPRESIDENT, DRUG DEV SOLUTIONSSSale−14.4K$16.85−$243.2K−22.4%50.1K after6 lots10b5-1
Apr 3, 2024 (view filing)Apr 12 daysTraynor Richard M.SVP AND GENERAL COUNSELSSale−3.00K$18.00−$54.0K−1.7%173.5K after10b5-1
Mar 5, 2024 (view filing)Mar 41 dayTraynor Richard M.SVP AND GENERAL COUNSELSSale−3.00K$18.28−$54.8K−1.8%162.4K after10b5-1
Feb 21, 2024 (view filing)Feb 201 daySmith Patrick FPRESIDENT, DRUG DEV SOLUTIONSSSale−5.00K$18.00−$90.0K−8.3%55.0K after10b5-1
Feb 14, 2024 (view filing)Feb 122 daysTraynor Richard M.SVP AND GENERAL COUNSELSSale−6.00K$18.00−$108.0K−3.5%165.4K after10b5-1
Dec 27, 2023 (view filing)Dec 261 dayTraynor Richard M.SVP AND GENERAL COUNSELSSale−6.00K$18.00−$108.0K−3.4%171.4K after10b5-1
Sep 12, 2023 (view filing)Sep 111 dayPedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFSSale−51.2K$14.60−$747.9K−28.4%128.9K after10b5-1
Aug 23, 2023 (view filing)Aug 21-222 daysBroshy EranDirectorPPurchase+5.00K$15.81+$79.1K+53.4%14.4K after2 lots
Jun 6, 2023 (view filing)Jun 51 daySmith Patrick FPRESIDENT, INTEGRATED DRUG DEVSSale−19.1K$21.55−$411.7K−24.2%60.0K after10b5-1
May 15, 2023 (view filing)May 114 daysTraynor Richard M.SVP AND GENERAL COUNSELSSale−5.00K$20.82−$104.1K−2.7%177.4K after10b5-1
Apr 17, 2023 (view filing)Apr 143 daysTraynor Richard M.SVP AND GENERAL COUNSELSSale−5.00K$23.66−$118.3K−2.7%182.4K after10b5-1
Mar 7, 2023 (view filing)Mar 61 dayTraynor Richard M.SVP AND GENERAL COUNSELSSale−10.0K$21.45−$214.5K−5.1%184.6K after
Feb 3, 2023 (view filing)Feb 21 dayTraynor Richard M.SVP AND GENERAL COUNSELSSale−15.0K$20.00−$300.0K−7.2%194.6K after
Dec 12, 2022 (view filing)4:16 PM ETDec 84 daysEQT Avatar Parent L.P. and 2 others10% OwnerSSale−30.0M$15.00−$449.3M−100.0%0 after
Nov 23, 2022 (view filing)Nov 221 dayPedersen Leif EPRESIDENT, SOFTWARESSale−51.2K$15.55−$796.5K−22.6%175.5K after
Nov 16, 2022 (view filing)Nov 14-152 daysSlaine Mason PDirectorSSale−250.0K$15.56−$3.89M−27.5%660.3K after2 lots
Nov 15, 2022 (view filing)Nov 141 dayWalsh Matthew MDirectorSSale−12.1K$14.74−$177.7K−6.7%167.9K after
Nov 14, 2022 (view filing)Nov 95 daysSmith Patrick FPRESIDENT, INTEGRATED DRUG DEVSSale−2.39K$13.48−$32.2K−3.1%74.9K after
Aug 23, 2022 (view filing)Aug 194 daysMcLean Stephen M.DirectorPPurchase+20.0K$16.32+$326.4K+90.9%42.0K after
Aug 18, 2022 (view filing)Aug 171 daySchemick Michael AndrewCHIEF FINANCIAL OFFICERPPurchase+25.0K$16.64+$416.0K+5.1%517.9K after
Aug 18, 2022 (view filing)Aug 162 daysSmith Patrick FPRESIDENT, INTEGRATED DRUG DEVSSale−10.0K$17.71−$177.1K−11.3%78.5K after
Aug 17, 2022 (view filing)5:01 PM ETAug 161 dayEQT Avatar Parent L.P. and 2 others10% OwnerSSale−6.00M$17.38−$104.4M−16.7%30.0M after
Aug 17, 2022 (view filing)Aug 161 daySlaine Mason PDirectorSSale−182.5K$17.38−$3.17M−16.7%910.3K after
Jun 9, 2022 (view filing)Jun 81 daySmith Patrick FPRESIDENT, INTEGRATED DRUG DEVSSale−10.0K$19.16−$191.6K−10.2%88.5K after
Jun 3, 2022 (view filing)Jun 21 daySlaine Mason PDirectorSSale−250.0K$19.56−$4.89M−18.6%1.09M after3 lots
Jun 1, 2022 (view filing)6:34 PM ETMay 311 dayEQT Avatar Parent L.P. and 2 others10% OwnerSSale−1.50M$19.00−$28.5M−4.0%36.0M after
Apr 5, 2022 (view filing)Apr 41 daySmith Patrick FPRESIDENT, INTEGRATED DRUG DEVSSale−3.35K$22.29−$74.7K−3.3%98.5K after
Mar 18, 2022 (view filing)Mar 162 daysTraynor Richard M.SVP AND GENERAL COUNSELSSale−3.00K$20.00−$60.0K−1.4%211.3K after
Mar 18, 2022 (view filing)Mar 16-172 daysSlaine Mason PDirectorSSale−250.0K$20.21−$5.05M−15.7%1.34M after2 lots
Mar 17, 2022 (view filing)Mar 161 dayFeehery William FCHIEF EXECUTIVE OFFICERSSale−62.5K$20.17−$1.26M−2.8%2.18M after
Mar 14, 2022 (view filing)Mar 113 daysFeehery William FCHIEF EXECUTIVE OFFICERSSale−27.5K$20.29−$558.3K−1.2%2.24M after
Feb 22, 2022 (view filing)Feb 184 daysFeehery William FCHIEF EXECUTIVE OFFICERSSale−75.0K$23.35−$1.75M−3.2%2.27M after2 lots
Feb 22, 2022 (view filing)Feb 175 daysFeehery William FCHIEF EXECUTIVE OFFICERSSale−90.0K$24.32−$2.19M−3.7%2.34M after3 lots
Feb 2, 2022 (view filing)Feb 11 daySlaine Mason PDirectorSSale−50.0K$26.61−$1.33M−3.0%1.59M after2 lots
Jan 27, 2022 (view filing)Jan 261 dayTraynor Richard M.SVP AND GENERAL COUNSELSSale−3.00K$26.01−$78.0K−1.4%214.3K after
Jan 27, 2022 (view filing)Jan 261 dayFeehery William FCHIEF EXECUTIVE OFFICERSSale−75.0K$25.37−$1.90M−3.0%2.43M after2 lots
Jan 21, 2022 (view filing)Jan 201 dayEdge JustinPRES., REGULATORY & ACCESSSSale−5.00K$27.50−$137.5K−1.2%397.1K after
Jan 20, 2022 (view filing)Jan 182 daysTraynor Richard M.SVP AND GENERAL COUNSELSSale−5.00K$27.44−$137.2K−2.2%217.3K after
Jan 4, 2022 (view filing)Jan 31 daySlaine Mason PDirectorSSale−50.0K$28.63−$1.43M−3.0%1.64M after2 lots
Dec 28, 2021 (view filing)Dec 271 dayTraynor Richard M.SVP AND GENERAL COUNSELSSale−3.00K$29.30−$87.9K−1.3%222.3K after
Dec 27, 2021 (view filing)Dec 234 daysCashman James E IIIDirectorSSale−25.1K$29.20−$733.2K−5.4%438.8K after
Dec 23, 2021 (view filing)Dec 221 dayCashman James E IIIDirectorSSale−19.9K$29.00−$576.8K−4.1%463.9K after
Dec 23, 2021 (view filing)Dec 221 dayFeehery William FCHIEF EXECUTIVE OFFICERSSale−75.0K$28.58−$2.14M−2.9%2.51M after
Dec 21, 2021 (view filing)Dec 201 dayChoe Jieun W.CHIEF STRATEGY & MARKETINGSSale−7.50K$28.00−$210.0K−2.9%250.5K after
Dec 20, 2021 (view filing)Dec 173 daysChoe Jieun W.CHIEF STRATEGY & MARKETINGSSale−5.00K$26.13−$130.7K−1.9%258.0K after
Dec 14, 2021 (view filing)4:27 PM ETDec 131 daySlaine Mason PDirectorSSale−50.0K$28.05−$1.40M−2.9%1.69M after2 lots